BIMI Holdings Inc.

Equities

BIMI

US05552Q3011

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-04-17 pm EDT 5-day change 1st Jan Change
1.412 USD -11.19% Intraday chart for BIMI Holdings Inc. +11.18% -35.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Top Premarket Decliners MT
BIMI International Medical, Inc. Announces Management Appointments CI
BIMI International Medical, Inc. has Changed its Name to BIMI Holdings Inc CI
BIMI International Medical, Inc. announced that it has received $3 million in funding CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BIMI International Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BIMI International Medical Gets Nasdaq Non-Compliance Notice for Late Quarterly Report MT
Earnings Flash (BIMI) BIMI INTERNATIONAL MEDICAL Reports Q1 Revenue $3.2M MT
BIMI International Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BIMI International Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BIMI International Medical, Inc. Auditor Raises 'Going Concern' Doubt CI
BIMI International Medical Receives Non-Compliance Notice From Nasdaq MT
BIMI International Medical Inc. Completed the acquisition of Phenix Bio Inc. from Fnu Oudom for $7.13 million. CI
BIMI International Medical, Inc. announced that it expects to receive $3 million in funding CI
Yu Xiang entered into an agreement to 87% stake in Chaohu Zhongshan Minimally Invasive Hospital from BIMI International Medical, Inc.. CI
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower MT
Top Premarket Decliners MT
BIMI International Medical Inc. cancelled the acquisition of Bengbu Mali Maternity Hospital from Renbao Chen and others. CI
BIMI International Medical Climbing in Late Trade After Contingent Payments From 2020 Purchase Returned MT
BIMI International to Effect 1-for-10 Reverse Stock Split; Shares Rise After-Hours MT
BIMI International Medical, Inc. announced that it has received $2 million in funding CI
BIMI International Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
BIMI International Medical, Inc. cancelled the transaction announced on November 17, 2021 CI
BIMI International Agrees to Sell Chonqing Zhuoda Pharmaceutical in China; to Focus on Growth in US MT
Three citizens of China entered into an agreement to acquire Chongqing Zhuoda Pharmaceutical Co, Ltd. from BIMI International Medical, Inc.. CI
Chart BIMI Holdings Inc.
More charts
BIMI Holdings Inc., formerly BIMI International Medical Inc., is a healthcare products and services provider. The Company offers a range of healthcare products and related services in the United States and Asia. The Company operates in four segments: wholesale pharmaceuticals, wholesale medical devices, medical services and retail pharmacy. The wholesale pharmaceuticals segment includes supplying prescription and over the counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug wholesalers. The wholesale medical devices segment distributes medical devices, including medical consumables, to private clinics, hospitals, third party pharmacies and other medical device dealers. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.
More about the company
  1. Stock Market
  2. Equities
  3. BIMI Stock
  4. News BIMI Holdings Inc.
  5. Earnings Flash (BIMI) BIMI INTERNATIONAL MEDICAL Reports Q2 Revenue $4.9M